Neonatal Hemochromatosis (Gestational Alloimmune Liver Disease)
Definition And Pathophysiology
- Single most common cause of acute liver failure during first month of life.
- Not a primary iron overload disease; secondary to severe fetal liver injury.
- Driven by gestational alloimmune liver disease (GALD) in nearly all cases.
- Maternal immune system sensitized to unknown fetal hepatocyte cell surface antigen.
- Maternal immunoglobulin G (IgG) crosses placenta, binding fetal liver antigens.
- Activates terminal complement cascade, forming C5b-9 membrane attack complex.
- Induces massive hepatocyte injury and death.
- Fetal liver injury impairs synthesis of iron regulatory and transport proteins (hepcidin).
- Impaired regulation causes excess non-transferrin-bound iron.
- Results in extrahepatic siderosis dictated by normal tissue capacity to import non-transferrin-bound iron.
- High recurrence rate in families; >90% probability subsequent infants affected.
Clinical Manifestations
- Presents at birth or within first few days of life.
- Prematurity or intrauterine growth restriction common.
- Jaundice, hypoglycemia, severe coagulopathy refractory to vitamin K.
- Hypoalbuminemia.
- Transaminases normal or mildly elevated, out of proportion to degree of liver failure.
Diagnostic Evaluation
- High serum ferritin, elevated alpha-fetoprotein, raised iron saturation.
- Extrahepatic iron deposition spares reticuloendothelial system.
- Magnetic resonance imaging (MRI) demonstrates extrahepatic siderosis in pancreas, myocardium, or thyroid follicles.
- Salivary gland/buccal submucosal biopsy confirms extrahepatic siderosis safely.
- Liver biopsy reveals acute and chronic inflammation, fibrosis, cirrhosis, absent surviving hepatocytes.
- Positive immunohistochemical staining for C5b-9 membrane attack complex on liver tissue.
Management And Prevention
Acute Postnatal Management
- Antioxidant cocktail (N-acetylcysteine, selenium, desferrioxamine, prostaglandin E1, vitamin E) historically utilized for iron chelation/free radical scavenging; lacks proven benefit.
- Intravenous immunoglobulin (IVIG) administration (1 g/kg) combined with exchange transfusion.
- Exchange transfusion removes circulating maternal IgG.
- IVIG/exchange transfusion significantly decreases need for liver transplantation.
- Liver transplantation indicated for failed medical management.
Antenatal Prevention
- Indicated for mothers with previously affected pregnancy.
- Maternal IVIG administration (1 g/kg bodyweight weekly).
- Initiated at 18 weeks gestational age; continued until end of gestation.
- Decreases GALD in developing fetus; achieves milder phenotypic expression and 100% infant survival.
Hereditary And Juvenile Hemochromatosis
Pathophysiology Of Iron Transport
- Normal intestinal iron absorption utilizes heme carrier protein 1 (HCP1) and divalent metal transporter 1 (DMT1) for apical uptake.
- Iron efflux at basolateral enterocyte membrane mediated by ferroportin 1.
- Hepatic hormone hepcidin controls plasma iron levels.
- Hepcidin binds ferroportin, inducing phosphorylation, internalization, and degradation of iron exporter.
- Hepcidin deficiency causes unchecked iron absorption and systemic iron overload.
Genetic Classification
| Disorder | Genetic Defect | Pathogenetic Mechanism |
|---|
| Classic Hemochromatosis | HFE gene variants (Cys282Tyr, His63Asn, Ser65Cys). | Reduces endocytic uptake of diferric transferrin by transferrin receptor-1 at basolateral membrane. |
| Juvenile Hemochromatosis (Type 2B) | Hepcidin gene mutations. | Primary hepcidin deficiency eliminates negative regulation of ferroportin, causing massive iron influx. |
| Hemochromatosis Type 4 | Ferroportin 1 gene mutations. | Autosomal dominant defect in iron exporter function. |
Clinical Manifestations
- Rare presentation in pediatric population.
- Progressive iron accumulation causes multiorgan dysfunction.
- Associated with bronze diabetes and arthropathy.
- Hepatomegaly, potential progression to cirrhosis.
Diagnostic Evaluation
- Markedly elevated serum ferritin and transferrin saturation.
- Hepatic iron content elevated on biopsy.
- HFE genetic testing confirms classic variants.
Differential Diagnosis Of Neonatal Liver Failure
Differentiating GALD/Neonatal Hemochromatosis from other acute neonatal liver failure etiologies requires careful biochemical correlation.
| Etiology | Transaminases (IU/L) | Coagulopathy (INR) | Ferritin (ng/mL) |
|---|
| Gestational Alloimmune Liver Disease (GALD) | Normal/mild increase (<100) | Significant increase | 800 - 7,000 |
| Hemophagocytic Lymphohistiocytosis (HLH) | Moderate/significant increase (>1,000) | Moderate/significant increase | Significant increase (>20,000) |
| Mitochondrial Hepatopathy | Moderate increase (100 - 500) | Moderate/significant increase | Variable |
| Viral Infection | Significant increase (>1,000) | Moderate/significant increase | Variable |
| Ischemic Hepatitis | Significant increase (>1,000 - 6,000) | Moderate/significant increase | Variable |